Regulus Therapeutics Inc.

Historical 13F Holders

Symbol
RGLS
CUSIP
75915K309
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 81 53.6 M $105 M
2024 Q4 72 53.5 M $84.5 M
2024 Q3 77 56.8 M $89.2 M
2024 Q2 70 55.0 M $98.1 M
2024 Q1 52 45.7 M $129 M
2023 Q4 30 9.17 M $11.7 M
2023 Q3 28 8.96 M $12.3 M
2023 Q2 28 8.23 M $12.1 M
2023 Q1 28 6.60 M $5.59 M
2022 Q4 32 6.71 M $9.20 M
2022 Q3 26 6.67 M $11.3 M
2022 Q2 29 4.62 M $9.57 M